Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

allogeneic human stem cell-derived pancreatic islet cells VX-880

A preparation of allogeneic human stem cell-derived, fully differentiated functional pancreatic islet cells, that can be used for islet cell transplantation for the treatment of type 1 diabetes mellitus. Upon infusion into the hepatic portal vein, allogeneic human stem cell-derived pancreatic islet cells VX-880 may replace and restore pancreatic islet cells, which are destroyed in patients with type 1 diabetes. These cells may restore pancreatic islet cell function, produce insulin and may regulate blood glucose levels.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:allogeneic human stem cell-derived beta cells VX-880
allogeneic human stem cell-derived islet cells VX-880
allogeneic stem cell-derived fully differentiated insulin-producing pancreatic islet cells VX-880
Code name:STx 02
STx-02
STx02
VX 880
VX-880
VX880
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search